Antimicrobial Agents Practice Questions

Q: What is the DOC for Extrapulmonary cryptococcal infection without CNS involvement?

Fluconazole. **Explanation:** The management of Cryptococcosis depends on the site of infection and the immune status of the patient. For **extrapulmonary cryptococcal infection without CNS involvement** (e.g., isolated pulmonary or soft tissue infection) in non-immunocompromised patients, **Fluconazole** is the Drug of Choice (DOC). **Why Fluconazole is correct:** Fluconazole is highly effective, has excellent oral bioavailability, and a superior safety profile compared to polyenes. For mild-to-moderate non-meningeal disease, it is administered at a dose of 400 mg daily for 6–12 months. It inhibits the fungal enzyme 14α-demethylase, preventing ergosterol synthesis. **Why other options are incorrect:** * **Amphotericin B:** This is the DOC for **disseminated or CNS cryptococcosis** (Cryptococcal Meningitis) as part of induction therapy. It is not used as monotherapy for mild extrapulmonary cases due to its significant nephrotoxicity. * **Flucytosine:** This is never used as monotherapy due to the rapid development of resistance. It is used strictly as an **adjunct** to Amphotericin B during the induction phase of meningitis. * **Azoles:** While Fluconazole is an azole, "Azoles" is too broad an option. Specifically, Fluconazole is preferred over Ketoconazole or Itraconazole due to better penetration and fewer side effects. **High-Yield NEET-PG Pearls:** 1. **Cryptococcal Meningitis DOC:** Induction with **Amphotericin B + Flucytosine** (2 weeks), followed by Consolidation and Maintenance with **Fluconazole**. 2. **Antigen Detection:** CrAg (Cryptococcal Antigen) via Lateral Flow Assay (LFA) is the most sensitive rapid diagnostic test. 3. **Staining:** **India Ink** preparation shows a "haloing" effect due to the thick polysaccharide capsule. 4. **Prophylaxis:** Primary prophylaxis is generally not recommended; however, secondary prophylaxis (maintenance) is mandatory in AIDS patients until immune reconstitution occurs.

Q: Peripheral neuritis is a complication of which drug?

Isoniazid. **Explanation:** **Isoniazid (INH)** is the correct answer because it interferes with the metabolism of **Pyridoxine (Vitamin B6)**. INH is chemically similar to pyridoxine and promotes its excretion in the urine. Additionally, it inhibits the enzyme *pyridoxine phosphokinase*, which converts B6 into its active form (pyridoxal phosphate). This deficiency leads to **peripheral neuropathy**, characterized by "glove and stocking" paresthesia [1]. This side effect is more common in "slow acetylators" and patients with pre-existing risks like diabetes, alcoholism, or malnutrition [1]. **Analysis of Incorrect Options:** * **Ethambutol:** Its most characteristic side effect is **Retrobulbar Neuritis**, which presents as decreased visual acuity and red-green color blindness. It does not typically cause peripheral nerve damage. * **Rifampicin:** Known for causing **hepatotoxicity** and a harmless **orange-red discoloration** of body fluids (urine, sweat, tears). It can also cause a "flu-like syndrome" if taken intermittently [4]. * **Pyrazinamide:** The most common side effects are **hyperuricemia** (leading to gout) and hepatotoxicity [3]. It is the most hepatotoxic drug among the first-line ATT. **High-Yield Clinical Pearls for NEET-PG:** * **Prevention:** Peripheral neuritis can be prevented by co-administering **Prophylactic Pyridoxine (10 mg/day)** [1]. * **Treatment:** If neuritis has already developed, the dose of Pyridoxine is increased to **100 mg/day**. * **Metabolism:** INH is metabolized by **Acetylation** (Phase II reaction) [2]. Slow acetylators are at higher risk for neuropathy, while fast acetylators are at higher risk for hepatotoxicity.

Q: Which tissue schizontocide prevents relapse of vivax malaria?

Primaquine. **Explanation:** The correct answer is **Primaquine**. **1. Why Primaquine is correct:** *Plasmodium vivax* and *Plasmodium ovale* have a unique life cycle stage called **hypnozoites**—dormant forms that remain in the liver (exoerythrocytic stage). These hypnozoites can "wake up" months or years later, causing a clinical **relapse**. Primaquine is the prototype **tissue schizontocide** that effectively kills these hepatic stages. It is the only drug (along with the newer Tafenoquine) used for the **radical cure** of vivax malaria to prevent recurrence. **2. Why other options are incorrect:** * **Chloroquine:** It is a potent **blood schizontocide**. While it is the drug of choice for treating the acute erythrocytic phase of malaria, it has no effect on the latent liver stages (hypnozoites). * **Quinine:** Another blood schizontocide used primarily for severe or chloroquine-resistant malaria. Like chloroquine, it cannot prevent relapses. * **Pyrimethamine:** This is a folate antagonist (DHFR inhibitor) used as a **slow-acting blood schizontocide** and a sporontocide. It does not eliminate hypnozoites. **3. High-Yield NEET-PG Pearls:** * **G6PD Deficiency:** Before prescribing Primaquine, patients **must** be screened for G6PD deficiency. The drug causes oxidative stress, leading to **acute hemolysis** in deficient individuals. * **Pregnancy:** Primaquine is **contraindicated** in pregnancy because the fetus is relatively G6PD deficient. * **Gametocidal Action:** Primaquine is also highly effective against the gametocytes of all species, including *P. falciparum*, thereby preventing the transmission of malaria to mosquitoes. * **Tafenoquine:** A long-acting analog of Primaquine that can be given as a single dose for radical cure.

Q: Which drug interferes with pyridoxine metabolism?

Isoniazid (INH). **Isoniazid (INH)** is the correct answer because it is a structural analogue of **Pyridoxine (Vitamin B6)**. It interferes with B6 metabolism through two primary mechanisms:1. It inhibits the enzyme **pyridoxine phosphokinase**, which converts pyridoxine into its active form, pyridoxal-5-phosphate (PLP).2. It reacts with PLP to form **isoniazid-pyridoxal hydrazones**, which are rapidly excreted in the urine.Since PLP is a vital cofactor for the synthesis of neurotransmitters like GABA, its deficiency leads to **peripheral neuropathy** (the most common side effect) [1] and, in rare cases, CNS toxicity/seizures [1].**Analysis of Incorrect Options:** * **Tetracycline:** Acts by inhibiting the 30S ribosomal subunit. Its major side effects involve bone/teeth discoloration and GI upset, not vitamin interference.* **Erythromycin:** A macrolide that inhibits the 50S ribosomal subunit. It is known for causing motilin-like GI effects and cholestatic jaundice.* **Rifampicin:** Inhibits DNA-dependent RNA polymerase. Its high-yield side effects include orange-colored body fluids and potent induction of Cytochrome P450 enzymes.**High-Yield Clinical Pearls for NEET-PG:** * **Prophylaxis:** To prevent neuropathy, INH is co-administered with **10–50 mg/day of Pyridoxine** [1].* **Risk Groups:** Malnourished individuals, alcoholics, diabetics [1], and **slow acetylators** (who have higher plasma levels of INH) [1] are at increased risk.* **Acute Toxicity:** In cases of INH overdose (presenting with seizures), intravenous Pyridoxine is the specific antidote.* **Sideroblastic Anemia:** INH can also cause this because PLP is a cofactor for ALA synthase, the rate-limiting enzyme in heme synthesis.

Q: Which ATT drug causes contact lens staining?

Rifampicin. **Explanation** **Rifampicin** is the correct answer because it is a potent inducer of hepatic enzymes and is excreted through various body fluids, including urine, sweat, saliva, and **tears**. Due to its intrinsic chemical structure, it imparts a characteristic **orange-red discoloration** to these secretions. In patients wearing soft contact lenses, the drug can permanently stain the lenses, leading to patient anxiety and the need for lens replacement. Patients should be counseled to switch to spectacles during the intensive phase of Antitubercular Therapy (ATT). **Analysis of Incorrect Options:** * **Isoniazid (INH):** Primarily associated with peripheral neuropathy (due to Vitamin B6 deficiency) and hepatotoxicity. It does not cause secretion discoloration. * **Streptomycin:** An aminoglycoside known for ototoxicity (vestibulocochlear nerve damage) and nephrotoxicity. It is administered parenterally and does not affect tear color. * **Pyrazinamide:** Most commonly associated with hyperuricemia (leading to gouty arthritis) and hepatotoxicity. It has no effect on contact lenses. **Clinical Pearls for NEET-PG:** * **Ethambutol (The "E" for Eye):** While Rifampicin stains lenses, Ethambutol causes **Retrobulbar Neuritis**, leading to decreased visual acuity and red-green color blindness. * **Rifampicin Mechanism:** Inhibits DNA-dependent RNA polymerase. * **Mnemonic:** Rifampicin makes everything **R**ed/**R**usty (Urine, Tears, Sweat). * **Drug Interactions:** Rifampicin is a powerful **CYP450 inducer**, which can decrease the efficacy of oral contraceptives and warfarin.

Q: Once weekly administration of which of the following antibiotics has prophylactic activity against bacteraemia caused by M.avium complex in AIDS patients?

Azithromycin. **Explanation:**The primary goal of prophylaxis against **Mycobacterium avium complex (MAC)** in HIV/AIDS patients (typically when CD4 counts fall below 50 cells/mm³) is to prevent disseminated infection. **1. Why Azithromycin is correct:**Azithromycin is a macrolide with a exceptionally long tissue half-life (approx. 68 hours). This pharmacokinetic property allows for once-weekly dosing (1200 mg) [1], which significantly improves patient compliance. It is the preferred agent for primary prophylaxis of MAC because it is effective, well-tolerated, and requires infrequent administration. **2. Why the other options are incorrect:** * **Clarithromycin:** While also a first-line agent for MAC, it has a much shorter half-life than azithromycin. It requires **twice-daily (BID)** administration for prophylaxis, making it less convenient than weekly azithromycin. * **Isoniazid:** This is the mainstay for *Mycobacterium tuberculosis* (TB) prophylaxis (Latent TB Infection), but it has no clinical activity against MAC. * **Rifabutin:** This is considered an alternative for MAC prophylaxis if macrolides are not tolerated. However, it must be administered **daily**, carries a risk of uveitis, and involves significant drug-drug interactions via CYP450 induction. **Clinical Pearls for NEET-PG:** * **Initiation Criteria:** MAC prophylaxis is indicated in HIV patients with **CD4 100 cells/mm³ for at least 3 months** in response to ART.

Q: Which of the following drug toxicities can be seen in Crigler-Najjar syndrome?

Atazanavir. **Explanation:** The correct answer is **Atazanavir**. **1. Why Atazanavir is correct:** Atazanavir is a Protease Inhibitor (PI) used in HIV treatment. Its primary metabolic pathway involves inhibition of the enzyme **UGT1A1 (UDP-glucuronosyltransferase)**. This enzyme is responsible for the conjugation of bilirubin in the liver. * **Crigler-Najjar Syndrome** is a genetic disorder characterized by a deficiency (Type II) or total absence (Type I) of UGT1A1. * When a patient with Crigler-Najjar syndrome (or the milder Gilbert syndrome) takes Atazanavir, the drug further inhibits the already deficient enzyme, leading to a significant rise in unconjugated bilirubin and clinical **jaundice/hyperbilirubinemia**. **2. Why the other options are incorrect:** * **Tenofovir (A):** A Nucleotide Reverse Transcriptase Inhibitor (NRTI) primarily associated with **nephrotoxicity** (Fanconi syndrome) and bone mineral density loss, not UGT inhibition. * **Zidovudine (B):** An NRTI known for **bone marrow suppression** (anemia, neutropenia) and mitochondrial toxicity (lactic acidosis). * **Nevirapine (D):** A Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) associated with severe **hepatotoxicity** and skin rashes (Stevens-Johnson Syndrome), but it does not specifically target the UGT1A1 pathway like Atazanavir. **Clinical Pearls for NEET-PG:** * **Atazanavir** is often called the "bananavir" in medical mnemonics because it causes yellowing of the skin (jaundice). * **Gilbert Syndrome:** Similar to Crigler-Najjar but milder; Atazanavir is also contraindicated or used with extreme caution here. * **Indinavir:** Another Protease Inhibitor that can cause hyperbilirubinemia and nephrolithiasis (kidney stones).

Q: Which of the following anti-TB drugs is NOT bactericidal?

Ethambutol. ### Explanation In the treatment of Tuberculosis, drugs are classified based on their mechanism of action as either **bactericidal** (killing the bacteria) or **bacteriostatic** (inhibiting growth). **Why Ethambutol is the correct answer:** Ethambutol is the only **bacteriostatic** drug among the first-line anti-TB agents. It works by inhibiting the enzyme **arabinosyl transferase**, which interferes with the synthesis of arabinogalactan, an essential component of the mycobacterial cell wall. Since it only halts the replication process rather than directly killing the bacilli, it is classified as bacteriostatic. **Why the other options are incorrect:** * **Rifampicin:** A potent **bactericidal** drug. It inhibits DNA-dependent RNA polymerase, preventing transcription. It is effective against both rapidly dividing and dormant (persister) bacilli. * **Isoniazid (INH):** Primarily **bactericidal** against rapidly dividing mycobacteria. It inhibits the synthesis of mycolic acids, which are vital for cell wall integrity. * **Pyrazinamide:** A **bactericidal** drug that is particularly effective in acidic environments (e.g., inside macrophages). It is crucial for killing intracellular organisms. **NEET-PG High-Yield Pearls:** * **Mnemonic for First-line Drugs:** **PRIEST** (Pyrazinamide, Rifampicin, Isoniazid, Ethambutol, STreptomycin). All are bactericidal **except** Ethambutol. * **Visual Side Effect:** Ethambutol is notorious for causing **Retrobulbar Neuritis**, leading to decreased visual acuity and **red-green color blindness**. (Remember: **E**thambutol for **E**ye). * **Sterilizing Activity:** Rifampicin and Pyrazinamide have the highest sterilizing activity, which helps in preventing relapses. * **Safe in Renal Failure:** Rifampicin and Isoniazid are primarily metabolized by the liver, while Ethambutol requires dose adjustment in renal impairment.

Q: What is the drug of choice for MRSA skin infection?

Vancomycin. **Explanation:** **Methicillin-resistant Staphylococcus aureus (MRSA)** is a major cause of skin and soft tissue infections (SSTIs). It is characterized by the presence of the **mecA gene**, which alters penicillin-binding proteins (PBP2a), rendering all beta-lactams (except 5th generation cephalosporins) ineffective. **Why Vancomycin is the Correct Answer:** **Vancomycin** (a glycopeptide) remains the traditional **Drug of Choice (DOC)** for serious systemic MRSA infections and complicated SSTIs. It works by inhibiting bacterial cell wall synthesis at the D-Ala-D-Ala terminus. In the context of NEET-PG, unless "oral" or "minor infection" is specified, Vancomycin is the gold standard for MRSA. **Analysis of Incorrect Options:** * **Linezolid (Option D):** While highly effective against MRSA and often used for skin infections due to its excellent tissue penetration, it is generally reserved as a second-line agent or for cases where IV access is difficult (due to 100% oral bioavailability). * **Quinupristin/Dalfopristin (Option C):** These are **Streptogramins (Option A)**. While they cover MRSA, they are primarily reserved for Vancomycin-resistant strains (VRSA) or Vancomycin-resistant Enterococcus (VRE) due to their significant side effect profile (e.g., infusion-site reactions, arthralgia). **High-Yield Clinical Pearls for NEET-PG:** * **Oral DOC for MRSA (Minor infections):** Cotrimoxazole, Clindamycin, or Doxycycline. * **Newer agents for MRSA:** Daptomycin (not used in pneumonia), Telavancin, and Ceftaroline (5th gen Cephalosporin). * **Mupirocin:** Topical drug of choice for MRSA colonization (nasal) and Impetigo. * **Red Man Syndrome:** A common side effect of Vancomycin due to histamine release (managed by slowing the infusion rate).

Question 1

What is the DOC for Extrapulmonary cryptococcal infection without CNS involvement?

Accepted Answer

Fluconazole

Answer

Amphotericin B

Answer

Flucytosine

Answer

Azoles

Question 2

Peripheral neuritis is a complication of which drug?

Accepted Answer

Isoniazid

Answer

Ethambutol

Answer

Rifampicin

Answer

Pyrazinamide

Question 3

Which tissue schizontocide prevents relapse of vivax malaria?

Accepted Answer

Primaquine

Answer

Quinine

Answer

Pyrimethamine

Answer

Chloroquine

Question 4

Which drug interferes with pyridoxine metabolism?

Accepted Answer

Isoniazid (INH)

Answer

Tetracycline

Answer

Erythromycin

Answer

Rifampicin

Question 5

Which ATT drug causes contact lens staining?

Accepted Answer

Rifampicin

Answer

Isoniazid (INH)

Answer

Streptomycin

Answer

Pyrazinamide

Question 6

Once weekly administration of which of the following antibiotics has prophylactic activity against bacteraemia caused by M.avium complex in AIDS patients?

Accepted Answer

Azithromycin

Answer

Clarithromycin

Answer

Isoniazid

Answer

Rifabutin

Question 7

Which of the following drug toxicities can be seen in Crigler-Najjar syndrome?

Accepted Answer

Atazanavir

Answer

Tenofovir

Answer

Zidovudine

Answer

Nevirapine

Question 8

What is the drug of choice for prophylaxis of tuberculosis?

Accepted Answer

Isoniazid

Answer

Rifampicin

Answer

Pyrazinamide

Answer

Streptomycin

Question 9

Which of the following anti-TB drugs is NOT bactericidal?

Accepted Answer

Ethambutol

Answer

Rifampicin

Answer

Isoniazid

Answer

Pyrazinamide

Question 10

What is the drug of choice for MRSA skin infection?

Accepted Answer

Vancomycin

Answer

Streptogramin

Answer

Quinupristin

Answer

Linezolid

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?